Alumis (ALMS) Stock Forecast, Price Target & Predictions
ALMS Stock Forecast
Alumis (ALMS) stock forecast, based on 8 Wall Street analysts, predicts a 12-month average price target of $39.17, with a high of $51.00 and a low of $25.00. This represents a 63.28% increase from the last price of $23.99.
ALMS Stock Rating
Alumis stock's rating consensus is Buy, based on 8 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 7 Buy (87.50%), 1 Hold (12.50%), 0 Sell (0.00%), and 0 Strong Sell (0.00%).
Buy
ALMS Price Target Upside V Benchmarks
| Type | Name | Upside |
|---|---|---|
| Stock | Alumis | 63.28% |
| Sector | Healthcare Stocks | 15.45% |
| Industry | Biotech Stocks | 41.48% |
Price Target Trends
| 1M | 3M | 12M | |
|---|---|---|---|
| # Anlaysts | - | - | 15 |
| Avg Price Target | - | - | $37.00 |
| Last Closing Price | $23.99 | $23.99 | $23.99 |
| Upside/Downside | - | - | 54.23% |
Ratings Trends
| Date | Strong Buy | Buy | Hold | Sell | Strong Sell | Total |
|---|---|---|---|---|---|---|
| Aug, 26 | 1 | 9 | 1 | - | - | 11 |
| Jul, 26 | 1 | 9 | 1 | - | - | 11 |
| Jun, 26 | 1 | 9 | 1 | - | - | 11 |
| May, 26 | 1 | 10 | - | - | - | 11 |
| Apr, 26 | 1 | 10 | - | - | - | 11 |
Analyst Price Target Forecasts
| Date | Analyst | Company | Price Target | Price when Published | Price Target/Price when Published | Price Target/Last Closing Price |
|---|---|---|---|---|---|---|
| May 19, 2026 | Chardan Capital | $40.00 | $21.09 | 89.66% | 66.74% | |
| May 15, 2026 | Terence Flynn | Morgan Stanley | $39.00 | $23.82 | 63.73% | 62.57% |
| May 15, 2026 | Wells Fargo | $51.00 | $24.63 | 107.06% | 112.59% | |
| May 15, 2026 | Yatin Suneja | Guggenheim | $34.00 | $24.63 | 38.04% | 41.73% |
| May 15, 2026 | Mitchell Kapoor | H.C. Wainwright | $25.00 | $24.63 | 1.50% | 4.21% |
| Mar 10, 2026 | Christopher Raymond | Raymond James | $46.00 | $28.10 | 63.70% | 91.75% |
| Jan 21, 2026 | Chardan Capital | $37.00 | $26.06 | 41.98% | 54.23% | |
| Jan 21, 2026 | Janani Sundararajan | Loop Capital Markets | $37.00 | $26.06 | 41.98% | 54.23% |
| Jan 09, 2026 | H.C. Wainwright | $40.00 | $18.18 | 120.02% | 66.74% | |
| Jan 07, 2026 | Morgan Stanley | $33.00 | $16.23 | 103.33% | 37.56% |
Analyst Rating Forecasts
| Date | Company | Previous Rating | New Rating | Rating Change |
|---|---|---|---|---|
| Aug 17, 2026 | Citigroup | Neutral | Neutral | hold |
| May 19, 2026 | Citigroup | Buy | Buy | hold |
| May 15, 2026 | Morgan Stanley | Overweight | Overweight | hold |
| May 15, 2026 | Wells Fargo | Overweight | Overweight | hold |
| May 15, 2026 | Guggenheim | Buy | Buy | hold |
| May 15, 2026 | H.C. Wainwright | Buy | Neutral | downgrade |
| Mar 10, 2026 | Raymond James | Strong Buy | initialise | |
| Jan 21, 2026 | Chardan Capital | Buy | initialise | |
| Jan 09, 2026 | H.C. Wainwright | Buy | Buy | hold |
| Jan 07, 2026 | Morgan Stanley | Overweight | Overweight | hold |
Financial Forecast
EPS Forecast
Annual
| Dec 23 | Dec 24 | Dec 25 | Dec 26 | Dec 27 | |
|---|---|---|---|---|---|
| Reported | $-2.99 | $-10.38 | $-2.86 | - | - |
| Avg Forecast | $-81.30 | $-8.15 | $-5.02 | $-4.31 | $-4.96 |
| High Forecast | $-81.30 | $-6.36 | $-4.13 | $-3.70 | $-3.67 |
| Low Forecast | $-81.30 | $-9.75 | $-5.68 | $-5.52 | $-6.54 |
| Surprise % | -96.32% | 27.36% | -43.03% | - | - |
Revenue Forecast
Annual
| Dec 23 | Dec 24 | Dec 25 | Dec 26 | Dec 27 | |
|---|---|---|---|---|---|
| Reported | - | - | $24.05M | - | - |
| Avg Forecast | - | - | - | - | $6.60M |
| High Forecast | - | - | - | - | $6.60M |
| Low Forecast | - | - | - | - | $6.60M |
| Surprise % | - | - | - | - | - |
Net Income Forecast
Annual
| Dec 23 | Dec 24 | Dec 25 | Dec 26 | Dec 27 | |
|---|---|---|---|---|---|
| Reported | $-154.99M | $-294.23M | $-243.32M | - | - |
| Avg Forecast | $-4.21B | $-417.61M | $-254.30M | $-239.00M | $-264.67M |
| High Forecast | $-4.21B | $-329.73M | $-214.12M | $-191.83M | $-190.27M |
| Low Forecast | $-4.21B | $-505.49M | $-294.48M | $-286.18M | $-339.06M |
| Surprise % | -96.32% | -29.54% | -4.32% | - | - |